Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 Healthcare Personalized medicine Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly detects activation of the... AseBio - VIVA IN VITRO
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 VIVA IN VITRO At a global scale, according to WHO data, between 48 and 50 million cases are estimated each year, with at least 11... AseBio - VIVA IN VITRO
Life Sciences Strategy: Europe’s commitment to remain a global leader in health 10/09/2025 Healthcare Growing investment in R&D, eliminating unnecessary bureaucratic hurdles, and creating governance structures of its own... AseBio
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financin... 10/09/2025 Healthcare Access to innovation Financing Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational... Partners - Asabys Partners
CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X ... 09/09/2025 Healthcare Access to innovation Financing CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Partners - CONNECTA THERAPEUTICS
Integra Therapeutics secures €10.7 million investment round to advance development of FiCA... 08/09/2025 Healthcare Advanced therapies Financing The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI Innvierte (Government... Partners - Integra Therapeutics S.L.
The microbiota revolution 08/09/2025 Healthcare The study of the microbiota has gone from a focus limited to digestion to become a pillar of preventive and personalised... Partners - GENESIS Biomed
SPEEDCELL, the new European project led by HIPRA, aims to reduce vaccine and biologics dev... 04/09/2025 Healthcare Access to innovation Innovative drugs With a duration of 4 years, this EU4Health program project aims to contribute to strengthening global health response... Partners - HIPRA HUMAN HEALTH S.L.U.
Pterovita® and Pteroyouth®: Spanish biotechnology for cell resilience and chronic disease ... 03/09/2025 Healthcare Access to innovation Innovative drugs CIRCE Health Science has developed Pterovita® and Pteroyouth®, ingredients that combine the application of crystal... Partners - BIOIB
XVII SDDN Meeting Hotel Attica 21, A Coruña, Galicia Spain Del 19/11/2025 to 21/11/2025 Healthcare Drug discovery
